{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:29Z","timestamp":1789506389057,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204047"],"award-info":[{"award-number":["82204047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272888"],"award-info":[{"award-number":["82272888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25TS1412200"],"award-info":[{"award-number":["25TS1412200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0917700"],"award-info":[{"award-number":["2024YFA0917700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["2022SKLY-12"],"award-info":[{"award-number":["2022SKLY-12"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12022106"],"award-info":[{"award-number":["SHDC12022106"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103014","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:10:29Z","timestamp":1787929829000},"page":"103014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-8963","authenticated-orcid":false,"given":"Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-5882","authenticated-orcid":false,"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruomeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanpeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103014_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian Cancer: A Review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.103014_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2407-14-171","article-title":"Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample","volume":"14","author":"Brain","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib5","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.103014_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.xcrm.2026.103014_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/cncr.30474","article-title":"Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years","volume":"123","author":"Pinsky","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.103014_bib9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jalm\/jfag044","article-title":"Correlates of Serum Concentrations of Biomarkers Relevant to Ovarian Cancer Screening","volume":"11","author":"Akonde","year":"2026","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.xcrm.2026.103014_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103014_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104001","article-title":"Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis","volume":"79","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.103014_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2011","article-title":"The blood peptidome: a higher dimension of information content for cancer biomarker discovery","volume":"6","author":"Petricoin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer's Achilles' heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103014_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1158\/2159-8290.CD-24-0393","article-title":"Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers","volume":"15","author":"Medina","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103014_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103014_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103014_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrclinonc.2018.21","article-title":"CancerSEEK and destroy\u2014a blood test for early cancer detection","volume":"15","author":"Killock","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","article-title":"Differential exoprotease activities confer tumor-specific serum peptidome patterns","volume":"116","author":"Villanueva","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103014_bib20","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.103014_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mas.21548","article-title":"Metabolomics toward personalized medicine","volume":"38","author":"Jacob","year":"2019","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.xcrm.2026.103014_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.103014_bib23","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/ac0352171","article-title":"Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry","volume":"76","author":"Villanueva","year":"2004","journal-title":"Anal. Chem."},{"key":"10.1016\/j.xcrm.2026.103014_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/prca.200600483","article-title":"Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS","volume":"1","author":"Jimenez","year":"2007","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.xcrm.2026.103014_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091629","article-title":"Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions","volume":"16","author":"Weaver","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.103014_bib26","doi-asserted-by":"crossref","first-page":"8737","DOI":"10.3390\/ijms23158737","article-title":"diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls","volume":"23","author":"Arenas-De Larriva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.103014_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103014_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/pr050034b","article-title":"Correcting common errors in identifying cancer-specific serum peptide signatures","volume":"4","author":"Villanueva","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1477-5956-7-34","article-title":"Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling","volume":"7","author":"Voortman","year":"2009","journal-title":"Proteome Sci."},{"key":"10.1016\/j.xcrm.2026.103014_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/prca.201600025","article-title":"Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer","volume":"10","author":"Rovithi","year":"2016","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.xcrm.2026.103014_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20240031","article-title":"The characterization of serum proteomics and metabolomics across the cancer trajectory in chronic hepatitis B-related liver diseases","volume":"5","author":"Xiao","year":"2024","journal-title":"View"},{"key":"10.1016\/j.xcrm.2026.103014_bib32","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acs.jproteome.2c00218","article-title":"Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry","volume":"21","author":"Huh","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12885-017-3467-2","article-title":"MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer","volume":"17","author":"Swiatly","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-019-0605-2","article-title":"Performance of matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib35","article-title":"Quantifiable TCR repertoire changes in prediagnostic blood specimens among patients with high-grade ovarian cancer","volume":"5","author":"Yu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103014_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-021-26642-9","article-title":"Multiplexed nanomaterial-assisted laser desorption\/ionization for pan-cancer diagnosis and classification","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103014_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17033-7","article-title":"Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona","volume":"11","author":"Blume","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103014_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12885-025-13652-9","article-title":"Protocol of the SOCFC project: a longitudinal cohort study of ovarian cancer patients, high-risk populations, and healthy controls to identify factors and biomarkers associated with disease diagnosis and prognosis","volume":"25","author":"Shi","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib39","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1501886","article-title":"Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition","volume":"196","author":"Cho","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103014_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.celrep.2014.02.014","article-title":"Autocrine effects of tumor-derived complement","volume":"6","author":"Cho","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103014_bib41","unstructured":"NCCN Guidelines Version 3.2025: Ovarian Cancer. (2025). https:\/\/www.nccn.org\/guidelines."},{"key":"10.1016\/j.xcrm.2026.103014_bib42","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib43","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13048-023-01222-1","article-title":"Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer","volume":"16","author":"Feng","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejso.2019.09.002","article-title":"Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis","volume":"46","author":"Cheng","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.xcrm.2026.103014_bib46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/ijmr.IJMR_817_18","article-title":"A systematic review on the prevalence of endometriosis in women","volume":"154","author":"Moradi","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","article-title":"Early Detection of Ovarian Cancer","volume":"32","author":"Elias","year":"2018","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.xcrm.2026.103014_bib48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nprot.2009.88","article-title":"Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry","volume":"4","author":"Villanueva","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.103014_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105706","article-title":"Serum metabolic fingerprints encode functional biomarkers for ovarian cancer diagnosis: a large-scale cohort study","volume":"115","author":"Liu","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.103014_bib50","first-page":"6143","article-title":"Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas","volume":"46","author":"Davis","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib51","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.3390\/ijms13089942","article-title":"Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry","volume":"13","author":"Weiland","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.103014_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123730","article-title":"CA125 and Ovarian Cancer: A Comprehensive Review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.103014_bib53","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib54","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1038\/srep09327","article-title":"Circulating peptidome to indicate the tumor-resident proteolysis","volume":"5","author":"Deng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103014_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2017.11.023","article-title":"Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment","volume":"85","author":"Ajona","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.103014_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215900","article-title":"The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells","volume":"549","author":"Senent","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.103014_bib57","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/pr400169n","article-title":"Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis","volume":"12","author":"Wu","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib58","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41388-025-03382-4","article-title":"Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer","volume":"44","author":"Wagner","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103014_bib59","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/pr060344+","article-title":"Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients","volume":"5","author":"Ogata","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.103014_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/IGC.0000000000000303","article-title":"Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism","volume":"25","author":"Man","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.xcrm.2026.103014_bib61","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1182\/blood.V108.11.1762.1762","article-title":"Hypercoagulability in Ovarian Cancer Revisited: A Prospective Analysis of Coagulation and Platelet Activation Markers","volume":"108","author":"Amirkhosravi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103014_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.xcrm.2026.103014_bib63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.280.8.719","article-title":"Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers","volume":"280","author":"Xu","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.103014_bib64","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/bib\/bbz070","article-title":"Consistency and overfitting of multi-omics methods on experimental data","volume":"21","author":"McCabe","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.xcrm.2026.103014_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1109\/34.75512","article-title":"Small sample size effects in statistical pattern recognition: Recommendations for practitioners","volume":"13","author":"Raudys","year":"1991","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"10.1016\/j.xcrm.2026.103014_bib66","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103014_bib67","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma proteomics","volume":"13","author":"Geyer","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2026.103014_bib68","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/SLA.0000000000002251","article-title":"A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement","volume":"267","author":"Chan","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xcrm.2026.103014_bib69","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5694\/mja2.52227","article-title":"Screening and prevention of ovarian cancer","volume":"220","author":"Sideris","year":"2024","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.xcrm.2026.103014_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.xcrm.2026.103014_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.xcrm.2026.103014_bib72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ije\/dyt043","article-title":"Markov chain Monte Carlo: an introduction for epidemiologists","volume":"42","author":"Hamra","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.xcrm.2026.103014_bib73","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1177\/0272989X17737507","article-title":"Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models","volume":"38","author":"Alagoz","year":"2018","journal-title":"Med. Decis. Mak."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:25Z","timestamp":1789503325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004313"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103014","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103014"}}